Related Experiment Videos
Inhibitors of dopamine inactivating systems as antiparkinson drugs
1Technion-Faculty of Medicine, Rappaport Family Research Institute, Department of Pharmacology, Haifa, Israel.
Advances in Neurology
|January 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The Involvement of Enkephalin System in Analgesia Induced by Brain Iron Deficiency.
Nutritional neuroscience·2016
Oxidative stress indices in Parkinson's disease : biochemical determination.
Methods in molecular medicine·2011
Serotonin neurochemistry revisited: A new look at some old axioms.
Neurochemistry international·2010
MAO-B inhibitors: multiple roles in the therapy of neurodegenerative disorders?
Parkinsonism & related disorders·2008
Behavior therapy: other interventions for tic disorders.
Advances in neurology·2006
Treatment of aggression in Tourette syndrome.
Advances in neurology·2006
Treatment of co-morbid obsessive compulsive disorder, mood, and anxiety disorders.
Advances in neurology·2006
Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs.
Advances in neurology·2006
Preclinical models relevant to Tourette syndrome.
Advances in neurology·2006
Aldosterone synthase inhibitors may alter how primary care treats hypertension.
American journal of hypertension·2026
The hypertension specialist's perspective: aldosterone synthase inhibitors to fill the gap in difficult-to-control and resistant hypertension.
American journal of hypertension·2026
From bench to formulary: a pharmacological appraisal of aldosterone synthase inhibitors for uncontrolled and resistant hypertension.
American journal of hypertension·2026
Lessons from the history of antipsychotic discovery: part 3 - muscarinic mechanisms.
BJPsych bulletin·2026
Topical and oral chemical pretreatments for photodynamic therapy in actinic keratoses: A scoping review.
Journal of photochemistry and photobiology. B, Biology·2026